A fast-acting treatment pill can help new moms with postpartum depression in just a couple of weeks — and it’s so new, many ...
Stocktwits on MSN
Johnson & Johnson’s Newly Acquired Antipsychotic Drug Approved By FDA For Major Depressive Disorder
The new approval is the first for the drug under JNJ leadership. ・The drug is also approved for the treatment of bipolar I ...
Caplyta, which J&J got in its acquisition of Intra-Cellular Therapies, netted a clearance in major depressive disorder that’s ...
Millions struggle with depression and anxiety, often enduring long waits for effective treatment. Scientists in Sweden, ...
Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration has further expanded the labeling ...
Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...
To provide some solid data, the authors of the new study gave LSD to a group of patients in New Zealand, and instructed them ...
Axsome Therapeutics has three drugs on the market and five in the pipeline, with the potential to help some 150 million Americans suffering from brain disorders. When Herriot Tabuteau started a drug ...
The FDA has approved a Transcranial Magnetic Stimulation device to treat adolescents with severe depression, offering a ...
A neuroscientist, he employed a battery of high-tech tools in devising a fast-acting therapy that targets the area of the ...
Moment of Clarity has published a new educational resource titled “Acccelerated TMS Therapy for Depression“, providing an in-depth look at how transcranial magnetic stimulation (TMS) technology is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback